LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 36 filers reported holding LANDOS BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,431,234 | -40.4% | 14,869,915 | 0.0% | 0.13% | -37.3% |
| Q4 2022 | $7,434,957 | -23.1% | 14,869,915 | 0.0% | 0.21% | -25.4% |
| Q3 2022 | $9,665,000 | -10.7% | 14,869,915 | 0.0% | 0.28% | -17.4% |
| Q2 2022 | $10,823,000 | -50.7% | 14,869,915 | 0.0% | 0.34% | -22.8% |
| Q1 2022 | $21,933,000 | -84.6% | 14,869,915 | -50.0% | 0.44% | -60.1% |
| Q4 2021 | $142,750,000 | -34.2% | 29,739,830 | +100.0% | 1.10% | -65.1% |
| Q3 2021 | $217,101,000 | -36.8% | 14,869,915 | -50.0% | 3.15% | +41.4% |
| Q2 2021 | $343,494,000 | +143.7% | 29,739,830 | +100.0% | 2.23% | +25.1% |
| Q1 2021 | $140,967,000 | – | 14,869,915 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $2,696,000 | 2.05% |
| Perceptive Advisors | 14,869,915 | $21,933,000 | 0.44% |
| RTW INVESTMENTS, LP | 4,275,722 | $6,307,000 | 0.13% |
| ArchPoint Investors | 128,750 | $190,000 | 0.07% |
| Orbimed Advisors | 283,217 | $418,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,000 | $235,000 | 0.01% |
| Walleye Capital LLC | 93,533 | $138,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 158,875 | $234,000 | 0.00% |
| Renaissance Technologies | 340,500 | $502,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,324 | $3,000 | 0.00% |